Researchers have discovered two new compounds that show promise in the fight against tuberculosis (TB) and neurodegenerative diseases such as Alzheimer's and Parkinson's. The compounds, called SQ109 and OPC-1671808, are both small molecules that can cross the blood-brain barrier, making them potentially effective in treating diseases that affect the central nervous system.
TB is a bacterial infection that primarily affects the lungs. It is the leading cause of death from infectious disease worldwide, with an estimated 1.5 million deaths in 2020. Neurodegenerative diseases are a group of conditions that are characterized by the progressive loss of neurons in the brain. They are a major cause of death and disability worldwide, and there are currently no effective treatments for most of these diseases.
The new compounds were discovered by a team of researchers at the University of California, San Francisco (UCSF). In a study published in the journal Nature, the researchers showed that SQ109 and OPC-1671808 were effective in killing TB bacteria in vitro and in animal models. The compounds were also shown to be effective in reducing the neuroinflammation and neuronal damage that are associated with neurodegenerative diseases.
"These compounds are a promising new lead in the fight against TB and neurodegenerative diseases," said study senior author Dr. Coleen K. Wu, a professor of microbiology and immunology at UCSF. "They are both small molecules that can cross the blood-brain barrier, which makes them potentially effective in treating diseases that affect the central nervous system."
The researchers are currently conducting clinical trials to evaluate the safety and efficacy of SQ109 and OPC-1671808 in humans. If these trials are successful, the compounds could become new treatments for TB and neurodegenerative diseases.
"The discovery of these new compounds is a major breakthrough in the fight against TB and neurodegenerative diseases," said Dr. Francis S. Collins, director of the National Institutes of Health (NIH). "These compounds have the potential to save millions of lives and improve the quality of life for millions more."
